Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 718 clinical trials in Bilthoven, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)The NetherlandsStudy of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients
The NetherlandsStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer
The NetherlandsStudy on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy
The NetherlandsStudy of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels
The NetherlandsStudy Comparing BGB-16673 to Drug Combinations for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Treated with BTK and BCL2 Inhibitors
The NetherlandsStudy of pneumococcal vaccines in healthy young adults, older adults and people with HIV infection
The NetherlandsThe NetherlandsStudy of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo
The NetherlandsStudy on How Mepolizumab Affects Patients with Chronic Rhinosinusitis with Nasal Polyps
The NetherlandsStudy on Flutemetamol (18F) for Detecting Amyloid Pathology in Cognitively Normal Elderly at Risk for Alzheimer's Disease
The NetherlandsStudy of Single-Dose Rabies Vaccine (Inactivated Flury LEP Strain) Immunity After Five Years: Testing Booster Response in Previously Vaccinated Adults
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Research focusing on optimizing vaccine effectiveness against multiple infectious diseases, including studies on meningococcal disease and influenza in different age groups.
Novel approaches include investigating optimal vaccination timing and early immunization strategies for enhanced protection.
Advanced studies in breast cancer treatment, examining innovative therapeutic combinations for hormone receptor-positive cases.
Investigations focus on optimizing treatment sequences to improve progression-free survival rates.
Clinical research examining surgical treatments combined with antibiotic therapy for improved patient outcomes.
Studies aim to enhance surgical outcomes through innovative combination therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
